A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Peng, Chien Hua ^a   Liao, Chun Ta ^a   Peng, Shih Chi ^a   Chen, Yin Ju ^a   Cheng, Ann Joy ^a   Juang, Jyh Lyh ^c   Tsai, Chi Ying ^a   Chen, Tse Ching ^a   Chuang, Yung Jen ^b   Tang, Chuan Yi ^d   Hsieh, Wen Ping ^b   Yen, Tzu Chen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d PROVIDENCE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN;

AMPLICON; ARTICLE; CANCER GENETICS; CANCER INVASION; CANCER RELAPSE; CANCER RISK; CARCINOGENESIS; CHROMOSOME 8Q; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DISEASE MARKER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUTH CARCINOMA; PREDICTIVE VALUE; PROGNOSIS; SECOND CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL; VALIDATION STUDY; CHROMOSOME 8; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENE REGULATORY NETWORK; GENETICS; HUMAN GENOME; METABOLISM; MORTALITY; MOUTH TUMOR; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE TRAIT; SURVIVAL RATE; SYSTEMS BIOLOGY; TUMOR GENE;

CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 8; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GENETIC LOCI; GENOME, HUMAN; HUMANS; MOUTH NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-MYC; QUANTITATIVE TRAIT, HERITABLE; SURVIVAL RATE; SYSTEMS BIOLOGY; TRANSCRIPTION, GENETIC;

EID: 80051635974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023452     Document Type: Article

References (43)

1. Cancela Mde C, Ramadas K, Fayette JM, Thomas G, Muwonge R, et al. (2009) Alcohol intake and oral cavity cancer risk among men in a prospective study in Kerala, India. Community Dent Oral Epidemiol 37: 342-349.
2. Liao CT, Wang HM, Chang JT, Ng SH, Hsueh C, et al. (2007) Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 110: 1501-1508.
3. Liao CT, Huang SF, Chen IH, Chang JT, Wang HM, et al. (2009) Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann Surg Oncol 16: 159-170.
4. Yen TC, Liao CT, (2010) Statistical Issues Involved in "Risk Stratification of Patients with Oral Cavity Squamous Cell Carcinoma and Contralateral Neck Recurrence Following Radical Surgery". Ann Surg Oncol.
5. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, et al. (2008) Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 15: 915-922.
6. Kane SV, Gupta M, Kakade AC, A DC, (2006) Depth of invasion is the most significant histological predictor of subclinical cervical lymph node metastasis in early squamous carcinomas of the oral cavity. Eur J Surg Oncol 32: 795-803.
7. Subapriya R, Thangavelu A, Mathavan B, Ramachandran CR, Nagini S, (2007) Assessment of risk factors for oral squamous cell carcinoma in Chidambaram, Southern India: a case-control study. Eur J Cancer Prev 16: 251-256.
8. Liu CJ, Chang KW, Chao SY, Kwan PC, Chang SM, et al. (2004) The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma. J Oral Pathol Med 33: 327-334.
9. Shah NG, Trivedi TI, Tankshali RA, Goswami JA, Shah JS, et al. (2007) Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression. Int J Biol Markers 22: 132-143.
10. Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, et al. (2005) Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res 11: 2272-2284.
11. Garnis C, Campbell J, Zhang L, Rosin MP, Lam WL, (2004) OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 40: 511-519.
12. da Silva Veiga LC, Bergamo NA, dos Reis PP, Kowalski LP, Rogatto SR, (2003) DNA gains at 8q23.2: a potential early marker in head and neck carcinomas. Cancer Genet Cytogenet 146: 110-115.
13. Sparano A, Quesnelle KM, Kumar MS, Wang Y, Sylvester AJ, et al. (2006) Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 116: 735-741.
14. Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, et al. (2010) Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 49: 9-16.
15. Broet P, Camilleri-Broet S, Zhang S, Alifano M, Bangarusamy D, et al. (2009) Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection. Cancer Res 69: 1055-1062.
16. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, et al. (2008) Genetics of gene expression and its effect on disease. Nature 452: 423-428.
17. Xu C, Liu Y, Wang P, Fan W, Rue TC, et al. (2010) Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival. Mol Cancer 9: 143.
18. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, et al. (2003) Genetics of gene expression surveyed in maize, mouse and man. Nature 422: 297-302.
19. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
20. Meyer N, Penn LZ, (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8: 976-990.
21. Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, et al. (2007) Non-transcriptional control of DNA replication by c-Myc. Nature 448: 445-451.
22. Herold S, Herkert B, Eilers M, (2009) Facilitating replication under stress: an oncogenic function of MYC? Nat Rev Cancer 9: 441-444.
23. Cheung VG, Spielman RS, (2009) Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat Rev Genet 10: 595-604.
24. Grigo K, Wirsing A, Lucas B, Klein-Hitpass L, Ryffel GU, (2008) HNF4 alpha orchestrates a set of 14 genes to down-regulate cell proliferation in kidney cells. Biol Chem 389: 179-187.
25. Black AR, Black JD, Azizkhan-Clifford J, (2001) Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160.
26. Seoane J, Le HV, Massague J, (2002) Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
27. Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J, (2001) Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol Cell Biol 21: 794-810.
28. Zhao L, Samuels T, Winckler S, Korgaonkar C, Tompkins V, et al. (2003) Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol Cancer Res 1: 195-206.
29. Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, et al. (2007) A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 67: 2951-2956.
30. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39: 638-644.
31. Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, et al. (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 42: 874-879.
32. Baek HJ, Malik S, Qin J, Roeder RG, (2002) Requirement of TRAP/mediator for both activator-independent and activator-dependent transcription in conjunction with TFIID-associated TAF(II)s. Mol Cell Biol 22: 2842-2852.
33. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, et al. (2007) High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215.
34. Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, et al. (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137: 873-886.
35. Proud CG, (2009) Dynamic balancing: DEPTOR tips the scales. J Mol Cell Biol 1: 61-63.
36. Iwanami A, Cloughesy TF, Mischel PS, (2009) Striking the balance between PTEN and PDK1: it all depends on the cell context. Genes Dev 23: 1699-1704.
37. Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, et al. (2006) Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol Cell 21: 393-404.
38. Liu X, Huang J, Chen T, Wang Y, Xin S, et al. (2008) Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. Cell Res 18: 1177-1189.
39. Hwang-Verslues WW, Sladek FM, (2008) Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol Endocrinol 22: 78-90.
40. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, et al. (2003) A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 100: 8164-8169.
41. Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, et al. (2010) A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143: 313-324.
42. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, et al. (2008) Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet 40: 1253-1260.
43. Bugrim A, Nikolskaya T, Nikolsky Y, (2004) Early prediction of drug metabolism and toxicity: systems biology approach and modeling. Drug Discov Today 9: 127-135.